Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.68p
   
  • Change Today:
    -0.025p
  • 52 Week High: 1.85p
  • 52 Week Low: 0.63p
  • Currency: UK Pounds
  • Shares Issued: 203.21m
  • Volume: 174,292
  • Market Cap: £1.37m
  • RiskGrade: 504
  • Beta: 0.48

Physiomics awarded further contracts with Merck

By Iain Gilbert

Date: Friday 22 Oct 2021

LONDON (ShareCast) - (Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it had been awarded two further contracts by existing client Merck.
Physiomics said the contracts, expected to be completed by the end of 2021, involved simulations of the clinical efficacy of drug products in Merck's DNA damage/repair portfolio.

Chief executive Dr Jim Millen said: "Merck remains a key, valued client and we are pleased to be continuing to work with them on a number of important development programs."

As of 0910 BST, Physiomics shares were down 0.66 at 6.06p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.68p
Change Today -0.025p
% Change -3.57 %
52 Week High 1.85p
52 Week Low 0.63p
Volume 174,292
Shares Issued 203.21m
Market Cap £1.37m
Beta 0.48
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.81% below the market average37.81% below the market average37.81% below the market average37.81% below the market average37.81% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Price Trend
87.71% below the market average87.71% below the market average87.71% below the market average87.71% below the market average87.71% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average
Income Not Available
Growth
56.08% below the market average56.08% below the market average56.08% below the market average56.08% below the market average56.08% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Physiomics Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
09:25 170,000 @ 0.69p
09:09 4,292 @ 0.70p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page